Verrica Pharmaceuticals Inc., a clinical-stage dermatology therapeutics company, is expected to break even by 2026. Analysts project a profit of US$2.0m after a final loss in 2025.
Read MoreDid you find this insightful?
Bad
Just Okay
Amazing
Verrica Pharmaceuticals Inc., a clinical-stage dermatology therapeutics company, is expected to break even by 2026. Analysts project a profit of US$2.0m after a final loss in 2025.
Read MoreDid you find this insightful?
Bad
Just Okay
Amazing
We are preparing, please wait
This content is only available for premium members. Please become a paid member to access.
Download AppCurrently, memberships can only be purchased through the app.